BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  rebetol: 2     
HTML
100%
Summary of opinion (initial authorisation) Ribavirin Three Rivers -- ribavirin
the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ribavirin Three Rivers, 200mg, Capsule, Hard intended for the treatment of chronic hepatitis C...
Pharma Live:  Mar 19 2010 4:45PM
Matching: rebetol 		Find similar documents
HTML
100%
Summary of opinion (initial authorisation) Ribavirin Three Rivers -- ribavirin
the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ribavirin Three Rivers, 200mg, Capsule, Hard intended for the treatment of chronic hepatitis C...
Therapeutics Daily:  Mar 19 2010 3:25PM
Matching: rebetol 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.